Please select an option below to help us tailor your newsletter to best suit your content interests!
Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee Pivotal study to determine the impact of Perimeter B-Series OCT with ImgAssist AI on positive margin rates during breast conservation surgery Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery… Read more »
The DeAngelo Williams Foundation doubled their donation to West Cancer Foundation, providing 106 mammograms to women in need with their 53 Strong for Sandra initiative West Cancer Foundation, whose mission is to advance the fight against cancer through research, education, patient support, and community outreach, announced today a donation to provide 106 mammograms to… Read more »
As a follow-up to the recent announcement of an initial study for the Cancer Care Pathway Initiative, available here, below is more detailed information about the findings and next steps: Study Overview: The Care Pathway Initiative recently conducted the first analysis of breast cancer care of its program. This baseline of quality metrics was… Read more »
Our team of 48 Medical Oncology & Hematology providers collaborate with highly specialized oncology experts to evaluate new research options and individual treatment plans. At West Cancer Center & Research Institute we offer the most comprehensive approach to cancer care. Our medical oncologists work closely with oncology surgeons, radiation oncologists, clinical researchers, radiologists, pathologists, genetic... Read more »
Nancy Childress is a metastatic breast cancer survivor, treated here at West Cancer Center. During the month of June, we asked our West family to share their stories of survivorship to help raise awareness for this disease and to encourage others currently fighting. Nancy was kind enough to share her story with us, written… Read more »
Results from a partnership to address disparities and enhance the quality of breast cancer care at Memphis-based West Cancer Center & Research Institute were announced today. The program is sponsored by Amgen. “Our goal is to reduce breast cancer-related mortality disparity rates of Black women in the Memphis area, where the current disparity rate is approximately 70 percent –… Read more »
The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »
Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »
Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer. Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »